Table 2.
Subunits of SRCAP and p400/TIP60 complexes implicated in cancer biology
| Subunits | Implication in cancer biology |
|---|---|
| BAF53a | Overexpressed in bladder, cervix, myeloma, colon, and ovarian cancers [21]; aberrant expression correlated with the progression of rhabdomyosarcoma, osteosarcoma, hepatocellular carcinoma, and head and neck squamous cell carcinoma [21]; BAF53a is considered to promote cancer progression via EMT epithelial–mesenchymal transition [22] |
| EPC1 | Is mutated by chromosomal translocation in endometrial stromal sarcoma and in adult T-cell leukaemia/lymphoma SO4 cells [23–25] |
| GAS41 | Overexpressed in glioblastoma cell lines [26, 27] |
| MRGBP/MRGX/MRG15 | Overexpressed in colorectal cancer tissues [28] |
| P400 | Its siRNA-mediated decrease favors the response to 5-fluorouracil of colon cancer cells [29] |
| Pontin & Reptin | Overexpressed in bladder, colon, liver cancers, and melanoma [21, 30, 31] |
| SRCAP | Mutated in large intestine, cervix, bone, endometrium, lung, urinary tract [21]; overexpressed in pancreatic cancer [21]; interacts with the CREB binding protein (CBP), an acetyltransferase encoded by a haplo-insufficient tumor suppressor gene in B-cell lymphoma [32]. It has been identified as a physiologically relevant mediator of PSA expression in prostate cancer cells [33] |
| Tip60 | Acts as a haplo-insufficient tumor suppressor [29, 34] |
| YL1 | Overexpressed in prostate cancer [35] |